首页|硝苯地平联合拉贝洛尔对妊娠高血压综合征患者分娩结局的影响

硝苯地平联合拉贝洛尔对妊娠高血压综合征患者分娩结局的影响

扫码查看
目的 观察硝苯地平联合拉贝洛尔对妊娠高血压综合征(pregnancy-induced hypertension syndrome,PIH)患者分娩结局的影响.方法 选取101例PIH患者,用随机数字法分为对照组(n=50)和试验组(n=51).对照组用硫酸镁联合硝苯地平治疗,试验组在对照组治疗的基础上联用拉贝洛尔.比较2组治疗前后的收缩压、舒张压及生化指标;比较2组的临床疗效、分娩结局及不良反应的发生情况.结果 治疗后,2组收缩压、舒张压、血清脑钠肽(brain natriuretic peptide,BNP)、胱抑素C(cystatin C,CysC)和尿微量白蛋白(microAlbunminuria,mALB)均降低(P<0.05),且试验组低于对照组(P<0.05).试验组的临床总有效率高于对照组(P<0.05);试验组宫内窘迫、胎盘早剥、早产和新生儿窒息的发生率明显低于对照组(P<0.05);2组头痛、胃肠道不适、乏力和低蛋白血症的发生率比较,差异无统计学意义(P>0.05).结论 硝苯地平联合拉贝洛尔可有效降低PIH患者的血压,改善其心、肾功能及妊娠结局,提升临床疗效,且安全性高.
Influence of nifedipine combined with labetalol on delivery outcomes in patients with gestational hypertension syndrome
Objective To observe the efficacy of nifedipine combined with labetalol on delivery outcomes in patients with pregnancy-induced hypertension(PIH).Methods A total of 101 patients with PIH were divided into control group(n=50)and experimental group(n=51)by using random number method.The control group was treated with magnesium sulfate combined with nifedipine,and the experimental group was treated with labetalol on the basis of the control group.The systolic blood pressure,diastolic blood pressure and biochemical indexes were compared between the 2 groups before and after treatment.The clinical efficacy,delivery outcome and adverse reactions of the 2 groups were compared.Results After treatment,the systolic blood pressure,diastolic blood pressure,serum brain natriuretic peptide(BNP),cystatin C(CysC),and urine microalbumin(mALB)levels in the 2 groups were decreased(P<0.05),and the experimental group was lower than the control group(P<0.05).The total clinical effective rate in the experimental group was higher than that in the control group(P<0.05).The incidences of intrauterine distress,placental abruption,premature birth and neonatal asphyxia in the experimental group were significantly lower than those in the control group(P<0.05).There was no significant difference in the incidence of headache,gastrointestinal discomfort,fatigue and hypoalbuminemia between the 2 groups(P>0.05).Conclusion Nifedipine combined with labetalol can effectively reduce blood pressure in patients with PIH,improve their cardio-renal function and pregnancy outcome,and improve clinical efficacy with high safety.

nifedipinelabetalolmagnesium sulfatepregnancy-induced hypertensiondelivery outcome

罗明、陈旭杰、刘小丽、郭巧云

展开 >

南阳市第二人民医院产一科,南阳 473000

河南省疾病预防控制中心,郑州 450016

硝苯地平 拉贝洛尔 硫酸镁 妊娠高血压 分娩结局

2021年度河南省医学科技攻关计划联合共建项目

LHGJ20210156

2024

西北药学杂志
西安交通大学,陕西省药学会

西北药学杂志

CSTPCD
影响因子:0.912
ISSN:1004-2407
年,卷(期):2024.39(4)